Seven Tips to Succeed in Pharma-Biotech Partnerships
The question of whether to partner with another company is critical to the long-term development…
The question of whether to partner with another company is critical to the long-term development…
The Belgian company Celyad has released the first interim clinical efficacy data for an off-the-shelf…
New approaches to tame the immune system in the fight against cancer are getting us…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
A new CAR-T cancer therapy from the Belgian company Celyad has shown early positive results…
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom…
Update (23/05/2018): Investors have fully subscribed Celyad's global offering of shares on NASDAQ and Euronext…
Celyad has reported clinical results showing the first time a patient has fully recovered from…
Most CAR-T stocks rose on the news that Big Biotech Celgene has plans to acquire…
European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’…
Celyad has started the SHRINK trial, which will evaluate the synergistic effects of the company's…
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…